Publication & Citation Trends
Publications
0 total
S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3) OA
Cited by 2
Semantic Scholar
POSTER: MM-246 Isatuximab (Isa) in Relapsed Multiple Myeloma (MM) Patients (pts) With Ultra-High-Risk (UHR) Cytogenetics: ICARIA-MM and IKEMA Subgroup Analysis OA
Cited by 0
Semantic Scholar
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis. OA
Cited by 2
Semantic Scholar
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study OA
Cited by 55
Semantic Scholar
EXCALIBER-RRMM: A phase 3, two-stage study of iberdomide, daratumumab, and dexamethasone (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
Cited by 7
Semantic Scholar
Safety and clinical activity of belantamab mafodotin plus lenalidomide and dexamethasone in transplant ineligible patients with newly diagnosed multiple myeloma: The phase 1/2, prospective, open-label, BelaRd study.
Cited by 2
Semantic Scholar
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron OA
Cited by 8
Semantic Scholar
MM-527 Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) OA
Cited by 2
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(1586)
Protein Degradation and Inhibitors
(590)
Cancer Treatment and Pharmacology
(424)
Chronic Lymphocytic Leukemia Research
(393)
Peptidase Inhibition and Analysis
(387)
Affiliations
University of Seoul
University of Iowa
University of Maryland, Baltimore
Mount Sinai Hospital
Piedmont Athens Regional